PT1428878E - Processo para a produção e purificação de eritropoietina - Google Patents

Processo para a produção e purificação de eritropoietina Download PDF

Info

Publication number
PT1428878E
PT1428878E PT02027952T PT02027952T PT1428878E PT 1428878 E PT1428878 E PT 1428878E PT 02027952 T PT02027952 T PT 02027952T PT 02027952 T PT02027952 T PT 02027952T PT 1428878 E PT1428878 E PT 1428878E
Authority
PT
Portugal
Prior art keywords
production
erythropoietin
purification
glycoproteins
purifying
Prior art date
Application number
PT02027952T
Other languages
English (en)
Inventor
Michael Bavand
Horst Blasey
Original Assignee
Bioceuticals Arzneimittel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32319603&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1428878(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioceuticals Arzneimittel Ag filed Critical Bioceuticals Arzneimittel Ag
Publication of PT1428878E publication Critical patent/PT1428878E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT02027952T 2002-12-13 2002-12-13 Processo para a produção e purificação de eritropoietina PT1428878E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02027952A EP1428878B1 (en) 2002-12-13 2002-12-13 Process for the production and purification of erythropoietin

Publications (1)

Publication Number Publication Date
PT1428878E true PT1428878E (pt) 2008-11-18

Family

ID=32319603

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02027952T PT1428878E (pt) 2002-12-13 2002-12-13 Processo para a produção e purificação de eritropoietina

Country Status (8)

Country Link
EP (1) EP1428878B1 (pt)
AT (1) ATE405644T1 (pt)
CY (1) CY1108571T1 (pt)
DE (1) DE60228460D1 (pt)
DK (1) DK1428878T3 (pt)
ES (1) ES2312523T3 (pt)
PT (1) PT1428878E (pt)
SI (1) SI1428878T1 (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7696163B2 (en) 2001-10-10 2010-04-13 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7795210B2 (en) 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
WO2004099231A2 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7157277B2 (en) 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
MXPA04012496A (es) 2002-06-21 2005-09-12 Novo Nordisk Healthcare Ag Glicoformos del factor vii pegilados.
NZ542094A (en) 2003-03-14 2008-12-24 Neose Technologies Inc Branched polymer conjugates comprising a peptide and water-soluble polymer chains
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
WO2006127896A2 (en) 2005-05-25 2006-11-30 Neose Technologies, Inc. Glycopegylated factor ix
AU2004240553A1 (en) 2003-05-09 2004-12-02 Neose Technologies, Inc. Compositions and methods for the preparation of human growth hormone glycosylation mutants
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US7956032B2 (en) 2003-12-03 2011-06-07 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
CN101072789B (zh) 2004-01-08 2013-05-15 生物种属学股份公司 肽的o-连接的糖基化
DE102004027816A1 (de) 2004-06-08 2006-01-05 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von Erythropoietin
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
EP1799249A2 (en) 2004-09-10 2007-06-27 Neose Technologies, Inc. Glycopegylated interferon alpha
EP1814573B1 (en) 2004-10-29 2016-03-09 ratiopharm GmbH Remodeling and glycopegylation of fibroblast growth factor (fgf)
CA2593682C (en) 2005-01-10 2016-03-22 Neose Technologies, Inc. Glycopegylated granulocyte colony stimulating factor
WO2006079155A1 (en) * 2005-01-25 2006-08-03 Apollo Life Sciences Limited Molecules and chimeric molecules thereof
US20060246544A1 (en) * 2005-03-30 2006-11-02 Neose Technologies,Inc. Manufacturing process for the production of peptides grown in insect cell lines
US9187546B2 (en) 2005-04-08 2015-11-17 Novo Nordisk A/S Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP1888098A2 (en) 2005-05-25 2008-02-20 Neose Technologies, Inc. Glycopegylated erythropoietin formulations
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
WO2007124750A2 (en) * 2006-04-27 2007-11-08 Syddansk Universitet Methods for isolation and analysis of sialylated and phosphorylated peptides
JP2009544327A (ja) 2006-07-21 2009-12-17 ノヴォ ノルディスク アー／エス Ｏ−結合型グリコシル化配列によるペプチドのグリコシル化
EP2054521A4 (en) * 2006-10-03 2012-12-19 Novo Nordisk As METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES
JP5065391B2 (ja) * 2006-12-06 2012-10-31 日本ケミカルリサーチ株式会社 ヒトエリスロポエチンの製造方法
KR20150064246A (ko) 2007-04-03 2015-06-10 바이오제너릭스 게엠베하 글리코페길화 ｇ―ｃｓｆ를 이용하는 치료 방법
US20100129932A1 (en) * 2007-06-05 2010-05-27 Loennberg Maria Determination of Isoerythropoietins
ES2551123T3 (es) 2007-06-12 2015-11-16 Ratiopharm Gmbh Proceso mejorado para la producción de azúcares de nucleótido
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
CN101965200B (zh) 2008-02-27 2013-06-19 诺沃-诺迪斯克有限公司 缀合的因子ⅷ分子
DE102008002209A1 (de) 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur Aufreinigung von Erythropoietin
US20120172299A1 (en) * 2008-09-23 2012-07-05 F. Hoffmann-La Roche Ag Purification of erythropoietin
KR20120117728A (ko) 2009-09-23 2012-10-24 바이오제너릭스 에이지 재조합 인간 에리트로포이에틴(ｅｐｏ)의 정제 방법, 이렇게 정제된 ｅｐｏ 및 이를 포함하는 약학적 조성물
WO2011063195A2 (en) * 2009-11-20 2011-05-26 Dr. Reddy's Laboratories Ltd. Purification of modified cytokines
SG181496A1 (en) * 2009-12-18 2012-07-30 Csl Ltd Method of purifying polypeptides
CA2831787A1 (en) 2011-03-29 2012-10-04 Glaxosmithkline Llc Buffer system for protein purification
KR101443257B1 (ko) * 2011-10-18 2014-09-19 주식회사 종근당 낮은 등전점을 갖는 에리스로포이에틴 유사체의 정제방법
WO2013153497A1 (en) 2012-04-10 2013-10-17 Dr. Reddy's Laboratories Limited Single step fractionation method
US10066001B2 (en) 2013-03-15 2018-09-04 Apotex Inc. Enhanced liquid formulation stability of erythropoietin alpha through purification processing
CN115032317B (zh) * 2022-06-29 2024-03-26 科兴生物制药股份有限公司 重组人***的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79176A (en) * 1985-06-20 1992-06-21 Kirin Amgen Inc Process for the recovery of erythropoietin from a fluid
WO1995007703A1 (en) * 1993-09-15 1995-03-23 Alpha Therapeutic Corp. Alpha1-acid glycoprotein purification process and product
IL117849A (en) * 1995-04-14 2002-07-25 Lepetit Spa Chromatographic process for clearing glycoproteins
IL118201A (en) * 1995-05-11 2004-12-15 Roche Diagnostics Gmbh Preparation comprising a protein with human erythropoietin activity which is free of serum and non-recombinant mammalian protein and process for the preparation thereof
RU2145610C1 (ru) * 1998-12-09 2000-02-20 Общество с ограниченной ответственностью "Протеиновый контур" Способ очистки рекомбинантного эритропоэтина человека
BR0214568A (pt) * 2001-11-28 2004-11-03 Sandoz Ag Purificação cromatográfica de eritropoietina humana recombinante

Also Published As

Publication number Publication date
DE60228460D1 (de) 2008-10-02
CY1108571T1 (el) 2014-04-09
SI1428878T1 (sl) 2009-02-28
ES2312523T3 (es) 2009-03-01
EP1428878B1 (en) 2008-08-20
ATE405644T1 (de) 2008-09-15
EP1428878A1 (en) 2004-06-16
DK1428878T3 (da) 2008-12-08

Similar Documents

Publication Publication Date Title
PT1428878E (pt) Processo para a produção e purificação de eritropoietina
MX2007003906A (es) Metodos y composiciones para mejorar la produccion de proteinas recombinantes.
DE69939901D1 (de) Verfahren und materialien zur herstellung von glucosamin
WO2007051038A3 (en) Pdx1-expressing dorsal and ventral foregut endoderm
ATE342962T1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
BR0012712B1 (pt) métodos de produção de l-aminoácidos aumentando-se o nadph celular.
ATE470702T1 (de) Verfahren zur herstellung von permanenten humanen zelllinien
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
WO2006052302A3 (en) Method of producing and purifying adenoviral vectors
CA2391098A1 (en) Recombinant .alpha.-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
ATE383417T1 (de) Produktion lymphoider gewebsspezifischer zellen von hämatopoietischen vorläuferzellen in einem dreidimensionalen system
DE69233558D1 (de) Keratinozyt-abstammende Granulate zur Verwendung als wundheilendes Mittel
IL184696A (en) Recombinant expression of vitamin k epoxide reductase subunit 1 to enhance protein expression dependent on vitamin k
DK0920448T3 (da) Trunkeret gliacellelinie-afledt neurotrof faktor
PL1861504T3 (pl) Glikoinżynieria grzybów
DE69929198D1 (de) Zellkulturverfahren für die produktion von glycoproteinen
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
DE50208601D1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
NZ595833A (en) Method of producing a lipolytic enzyme
EP2067857A4 (en) PROCESS FOR PRODUCING DIPEPTIDE
ATE413451T1 (de) Methoden zur massenkultivierung von zellen die rekombinantes menschliches erythropoietin produzieren
WO2004076624A3 (en) Compositions and methods for neural cell production and stabilization
GB2440490A (en) Method for preparing a target protein using the sHSPs
DE602004031117D1 (de) Verfahren zur herstellung differenzierter hämatopoetischer zellen zur behandlung von zytopenie
WO2003080806A3 (en) Method for production of neutrophils and uses therefor